The fertility test market is projected to reach USD 680 Million by 2025 from USD 472 Million in 2020, at a CAGR of 7.5 % the forecast period, according to a new report by MarketsandMarkets™. Growth in this market is primarily driven by by the increasing first-time pregnancy age in women, declining fertility rate among men and women, growing number of women suffering from disorders such as PCOS, emergence of advanced ovulation monitors, and the increased awareness of fertility testing in both developed as well as developing countries.
Browse in-depth TOC on “Fertility Test Market”
161 – Tables
35 – Figures
183 – Pages
Overview:
This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139945432
Secondary Research:
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the fertility test market. A database of the key industry leaders was also prepared using secondary research.
Primary Research:
Primary research was conducted after acquiring extensive knowledge about the global fertility test market scenario through secondary research. Primary interviews were conducted with market experts from both the demand-side (such as hospitals, fertility clinics, research universities, academic institutions, and government institutions, among others) and supply-side respondents (such as presidents, CEOs, vice presidents, directors, general managers, heads of business units, and senior managers) across five major geographies, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East, and Africa. Approximately 30% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 70%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.
Recent Developments:
# February 2021, Fertility Focus partnered with ExSeed Health, a home-based sperm testing company. Under this partnership, both companies would together provide solutions to couples planning a pregnancy.
# May 2019, Fertility Focus (UK) launched an updated version of OvuSense App— OvuSense App v.2—with features such as increased flexibility in data viewing (three different ways), more choices for logging events than most of the apps, and increased accuracy in terms of monitoring cycles.
# January 2017, NFI Consumer Healthcare (US), a division of Gregory Pharmaceutical Holdings (US), completed the acquisition of the e.p.t OTC pregnancy.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=139945432
Restraint: Lesser precision of ovulation prediction kits
Ovulation prediction kits measure the luteinizing hormone (LH) surge that precedes about 24–36 hours prior to ovulation. These kits, however, cannot accurately confirm ovulation. In conditions such as luteinized unruptured follicle syndrome (in which a woman’s egg fails to emerge from its follicle after the LH surge occurs), ovulation predictors fail to give accurate results. Also, urinary LH measurement is only predictive of the onset of ovulation and cannot determine the date of ovulation or anovulation, thereby only indicating a very small period (of only about two days) of the fertile window.
Opportunity: Emerging nations to offer new growth avenues
Emerging markets such as China, India, Brazil, and Mexico are expected to offer significant growth opportunities to players operating in the fertility test market. The demand for fertility and ovulation monitors in emerging countries is expected to grow significantly in the coming years due to the rising infertility rates, increasing prevalence of PCOS and obesity, growing fertility education, and easy availability of fertility monitors through e-commerce websites, pharmacies, and retail shops/drugstores. In addition, friendly regulatory policies and less competition among players in developing markets (as compared to developed markets) have encouraged companies to focus on emerging countries.
Browse Adjacent Market: Medical Devices Market Research Reports & Consulting
Related Reports:
Infertility Treatment Market by Product (Equipment, Media, Accessories), Procedure (ART (IVF,ICSI, Surrogate), Insemination, Laparoscopy, Hysteroscopy, Patient Type (Female, Male), End User (Fertility Clinics, Hospitals, Research) – Global Forecast to 2026
https://www.marketsandmarkets.com/Market-Reports/infertility-treatment-devices-market-43497112.html
